Prostate Cancer Trials

171 Trials
RECRUITING
≥ 18 Years

Summary: This is a multicenter, open-label, Phase 1 study that will be conducted in two parts. Part 1 is the dose escalation of APG-5918. Part 2 is the dose ex...

RECRUITING
≥ 18 Years

Summary: Molecular Imaging (MI) uses tracers which emit radiation to provide clinically valuable imaging for patient with cancer. Most current MI agents utiliz...

RECRUITING
15 - 75 Years

Summary: To determine the Maximum Tolerated Dose (MTD) of CycloSam®, Samarium-153-DOTMP (Sm-153-DOTMP), a radiopharmaceutical that delivers radiation to the bo...

RECRUITING
≥ 18 Years

Summary: This is a first-in-human, open-label, multicenter, Phase 1 study to evaluate the safety, tolerability and preliminary efficacy of IPH4502 and to deter...

RECRUITING
≥ 18 Years

Summary: The intent of this study is to evaluate actionable outputs from TRAQinform Theranostics in a prospective, multi-center, non-interventional clinical st...

RECRUITING
≥ 18 Years

Summary: The goal of this clinical trial is to learn about the tolerability of telmisartan in patients with prostate cancer....

RECRUITING
≥ 18 Years

Summary: AGX101 is an antibody-drug conjugate (ADC) therapy for tumor-forming cancers. The purpose of this study is to learn about AGX101 effects and safety at...

RECRUITING
≥ 18 Years

Summary: This study is being done to determine if patients receiving personalized exercise therapy (versus those who do not receive personalized exercise thera...

RECRUITING
18 - 100 Years

Summary: The investigators will study SPECT imaging of radiopharmaceutical therapies given as standard of care or as part of other compatible research protocol...

RECRUITING
≥ 1 Year Years

Summary: This protocol is comprised of three unblinded, randomized, single-center studies to evaluate the impact of immediate versus three-month delayed compre...

RECRUITING
≥ 18 Years

Summary: This study will use different types of medical imaging to assess how lesions from advanced prostate cancer become resistant to second-generation AR-ta...

RECRUITING
≥ 18 Years

Summary: This Phase 1, multi-center, open-label, dose escalation and dose optimization study is designed to assess the safety, tolerability, pharmacokinetics (...

RECRUITING
All Ages

Summary: This study will use PET scans, which is a type of x-ray test that uses a radiotracer, to see whether these scans may be better able to find places in ...

RECRUITING
≥ 18 Years

Summary: This is a multi-cohort single arm phase II/screening trial of the combination of a fusion protein that binds EphrinB2 and blocks interaction with cell...